Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
NCR Atleos heads into its November 5 earnings date with short sellers quietly reducing exposure and the lending market showing no meaningful stress, leaving analysts' cautious consensus as the most interesting tension in the stock.
Short sellers have been trimming positions. At 5.7% of the free float, short interest is down 3.4% on the week and roughly flat over the past month, having slipped from a local peak above 4.5 million shares in mid-September to just under 4.2 million now. The borrow market is relaxed. Cost to borrow has fallen sharply, down 19% on the week to 0.34%, its lowest level in six weeks. Availability is exceptionally loose at 9,380%, meaning shares to borrow vastly outnumber the existing short position. Nothing in the lending market suggests pressure on bears. The options book confirms the same: the put/call ratio at 0.28 is close to its 20-day average of 0.28 and well below its 52-week high of 1.45, pointing to no particular demand for downside protection ahead of the print.
The Street sits in neutral territory, and the consensus has drifted there from a more positive starting point. Wedbush downgraded to Neutral in late February while paradoxically lifting its target to $50.40 from $45; DA Davidson made the same move at the same time, cutting from Buy to Neutral and dropping the target to $50 from $60. The mean target now stands at $50.20 against a current price of $45.47, implying around 10% upside, but the direction of travel among analysts has been downward despite the stock's resilience. The bear case centres on an EBITDA ratio that slipped to roughly 3.2x from 3.6x the previous quarter and the longer-run risk of declining bank teller volumes undermining ATM demand. Bulls counter with a projected mid-teens EBITDA compound growth rate over three to five years and a potential threefold increase in free cash flow, driven by ATM-as-a-Service contract economics. Valuation multiples have compressed modestly over the past 30 days, with the PE multiple down nearly a full turn to 8.9x and EV/EBITDA edging lower to 6.2x, modest readings that reflect the market's wait-and-see stance. Factor scores are mixed: the 90-day EPS momentum rank is solid at 73, but the 30-day reading has dropped to 22, suggesting near-term estimate revisions have turned less favourable.
Ownership is dominated by passive index money, with BlackRock at 14.6% and two Vanguard entities together above 11%. Bank of America reported a 5.2% stake in August. None of the filers have filed a Schedule 13D, so no activist intent is on the register. Engine Capital holds 3.5% but filed no changes at the last report date. The insider register shows only compensation mechanics in the recent window: the General Counsel exercised options and surrendered shares for tax on October 1, a standard M/F transaction pair with no discretionary character. The most recent open-market activity of note was a CEO grant back in March, also a compensation award rather than a market purchase.
The most telling data point ahead of November 5 may be the short score's direction rather than its level. The ORTEX short score has drifted down from 46.3 on September 29 to 44.5 today, moving away from the more elevated readings of late September. That deceleration in bearish signal, combined with short interest easing and borrow costs falling, paints a picture of positioning that is becoming less defensive into the print, not more. The prior two earnings reactions have been muted, a gain of less than 1% on the day in August and a loss of less than 1% the previous quarter, with the largest one-day move in the recent record being a 2.8% gain in June. The November 5 report is therefore less about whether the short base will be caught wrong and more about whether the Street's cautious consensus can be nudged back toward a more constructive view.
See the live data behind this article on ORTEX.
Open NATL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
